New hope for transplant patients battling severe immune reaction
Disease control
Recruiting now
This early-stage trial is testing a new oral medication called AC-003 for patients with a severe immune system complication called acute graft-versus-host disease (aGVHD) that can occur after a stem cell transplant. The study aims to find a safe dose and see if the drug can help …
Phase: PHASE1 • Sponsor: Accro Bioscience (Suzhou) Limited • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC